Stratos Genomics Raises $20M to Commercialize Fast DNA Sequencing Technology

  An illustration of Stratos Genomic’s DNA sequencing technology in action. (Stratos Genomics Photo)

An illustration of Stratos Genomic’s DNA sequencing technology in action. (Stratos Genomics Photo)

Congratulations to B2Launch client, Stratos Genomics, for raising another $20 million to finalize commercialization of its' next generation sequencing technology!

“We are excited that our vision of introducing a transformative next generation sequencing platform to the healthcare and research markets is approaching realization,” said Mark Kokoris, Stratos Genomics CEO, in a statement. “Our recent development breakthroughs put us in position to evaluate a number of strategic options and open discussions with partners who share our vision.”

Read more in coverage by Geekwire